IBRANCE Archives - Express Pharma

Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market

Pfizer to sell all its drugs in LICs at non-profit price

Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030

Pfizer files patent infringement petition in US court against Aurobindo, Dr Reddy’s

IBRANCE (palbociclib) fails trial for early breast cancer treatment